Dr. Linda Vahdat on Glembatumumab Vedotin as a Treatment in Triple Negative Breast Cancer
Linda Vahdat, MD, discusses the antibody drug conjugate glembatumumab vedotin being used in the treatment of women with triple negative breast cancer who have a high expression of gpNMB.